DIA Offers Clinical Safety and Pharmacovigilance Certification

Wednesday, December 30, 2009 07:21 AM

The Drug Information Association (DIA) recently launched its Clinical Safety and Pharmacovigilance Certificate Program—the organization’s third certificate program for clinical research professionals.

The new program focuses on topics related to pre- and postmarketing clinical safety and pharmacovigilance, risk-management strategies, safety inspections, signal detection and data mining, medical approaches in diagnosis and management of adverse drug reactions and drug safety surveillance and epidemiology.

Enrollment in the program is free, and fees for each course vary based on length.

Share:          
CWWeekly

May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs